Bullfrog AI Holdings, Inc. (BFRG)

NASDAQ: BFRG · IEX Real-Time Price · USD
3.210
-0.250 (-7.23%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Company Description

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.

The company offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease.

The company was founded in 2017 and is based in Gaithersburg, Maryland.

Bullfrog AI Holdings, Inc.
Bullfrog AI Holdings logo
Country United States
Founded 2017
IPO Date Feb 14, 2023
Industry Health Information Services
Sector Healthcare
Employees 11
CEO Vininder Singh

Contact Details

Address:
325 Ellington Blvd., Unit 317
Gaithersburg, Maryland 20878
United States
Phone (301) 367-2055
Website bullfrogai.com

Stock Details

Ticker Symbol BFRG
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $6.50
CIK Code 0001829247
ISIN Number US12021E1091
Employer ID 84-4786155
SIC Code 2834

Key Executives

Name Position
Vininder Singh Founder, Chairman and Chief Executive Officer
Dane R. Saglio Chief Financial Officer
J. T. Koffenberger Chief Information Officer
Dr. Thomas E. Chittenden DPHIL, Ph.D. Chief Scientific Officer
Dr. Cetin Savkli Chief AI Advisor and Member of Advisory Board
William Hirschman Chief Commercial Officer
Dr. David P. Recker FACP, FACR, M.D. Chief Medical Officer

Latest SEC Filings

Date Type Title
Mar 8, 2024 8-K Current Report
Feb 26, 2024 8-K Current Report
Feb 9, 2024 8-K Current Report
Feb 6, 2024 8-K Current Report
Feb 2, 2024 424B3 Prospectus
Jan 31, 2024 EFFECT Notice of Effectiveness
Jan 29, 2024 S-1 General form for registration of securities under the Securities Act of 1933
Jan 26, 2024 8-K Current Report
Jan 24, 2024 UPLOAD Filing
Jan 23, 2024 144 Filing